Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution

被引:118
作者
Natsugoe, S. [1 ]
Okumura, H. [1 ]
Matsumoto, M. [1 ]
Uchikado, Y. [1 ]
Setoyama, T. [1 ]
Yokomakura, N. [1 ]
Ishigami, S. [1 ]
Owaki, T. [1 ]
Aikou, T. [1 ]
机构
[1] Kagoshima Univ, Sch Med, Dept Surg Oncol & Digest Surg, Kagoshima 890, Japan
关键词
chemoradiation therapy; esophageal cancer; randomized controlled study;
D O I
10.1111/j.1442-2050.2006.00615.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The purpose of the present study was to compare the clinical results between preoperative chemoradiotherapy followed by surgery (CRT group) and surgery alone (Surgery group) by a randomized controlled study. Twenty-two patients were assigned to the CRT group and 23 to the Surgery group. A total radiation dose of 40 Gy was applied and in the same period, intravenous chemotherapy was performed using cisplatin (7 mg over 2 h) and 5-fluorouracil (5-FU; 350 mg over 24 h). Surgical treatment was performed in 20 patients in the CRT group except for two patients with bone metastasis after CRT. According to histological effects of primary tumors, the number of patient with Grades 1, 2 and 3 was 11, 7 and 3, respectively. Frequency of lymphatic and venous invasion was significantly lower in the CRT group than in the Surgery group. The 5-year survival rate was 57% in the CRT group and 41% in the Surgery group (P = 0.58). According to the histological effect in the CRT group, 5-year survival was 30% for Grade 1, 83% for Grade 2 and 100% for Grade 3 (P = 0.0069). This randomized trial did not demonstrate a statistically significant survival difference between the CRT group and the Surgery group.
引用
收藏
页码:468 / 472
页数:5
相关论文
共 36 条
  • [1] Ancona E, 2001, CANCER, V91, P2165, DOI 10.1002/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.3.CO
  • [2] 2-8
  • [3] Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study - JCOG9204
    Ando, N
    Iizuka, T
    Ide, H
    Ishida, K
    Shinoda, M
    Nishimaki, T
    Takiyama, W
    Watanabe, H
    Isono, K
    Aoyama, N
    Makuuchi, H
    Tanaka, O
    Yamana, H
    Ikeuchi, S
    Kabuto, T
    Nagai, K
    Shimoda, Y
    Kinjo, Y
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) : 4592 - 4596
  • [4] LONG-TERM RESULTS OF SUBTOTAL ESOPHAGECTOMY WITH 3-FIELD LYMPHADENECTOMY FOR CARCINOMA OF THE THORACIC ESOPHAGUS
    BABA, M
    AIKOU, T
    YOSHINAKA, H
    NATSUGOE, S
    FUKUMOTO, T
    SHIMAZU, H
    AKAZAWA, K
    [J]. ANNALS OF SURGERY, 1994, 219 (03) : 310 - 316
  • [5] Prospective evaluation of preoperative chemotherapy in resectable squamous cell carcinoma of the thoracic esophagus
    Baba, M
    Natsugoe, S
    Shimada, M
    Nakano, S
    Kusano, C
    Fukumoto, T
    Aikou, T
    Akazawa, K
    [J]. DISEASES OF THE ESOPHAGUS, 2000, 13 (02) : 136 - 141
  • [6] Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus
    Bosset, JF
    Gignoux, M
    Triboulet, JP
    Tiret, E
    Mantion, G
    Elias, D
    Lozach, P
    Ollier, JC
    Pavy, JJ
    Mercier, M
    Sahmoud, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (03) : 161 - 167
  • [7] Boyle MJ, 2001, AM SURGEON, V67, P956
  • [8] Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
    Burmeister, BH
    Smithers, BM
    Gebski, V
    Fitzgerald, L
    Simes, RJ
    Devitt, P
    Ackland, S
    Gotley, DC
    Joseph, D
    Millar, J
    North, J
    Walpole, ET
    Denham, JW
    [J]. LANCET ONCOLOGY, 2005, 6 (09) : 659 - 668
  • [9] Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy
    Doty, JR
    Salazar, JD
    Forastiere, AA
    Heath, EI
    Kleinberg, L
    Heitmiller, RF
    [J]. ANNALS OF THORACIC SURGERY, 2002, 74 (01) : 227 - 231
  • [10] *ES DIS RES SOC, 1999, GUID CLIN PATH STUD